News
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...
Furthermore, objective response rate of subgroups in liver metastasis, bladder cancer and tumor with negative expression of Nectin-4 were 88.2%, 94.4%, 100%, respectively. This demonstrates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback